vimarsana.com

Latest Breaking News On - Institutional investment management - Page 1 : vimarsana.com

Gregory Orenstein Sells 7,943 Shares of nCino, Inc (NASDAQ:NCNO) Stock

nCino, Inc. (NASDAQ:NCNO – Get Free Report) CFO Gregory Orenstein sold 7,943 shares of the business’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $30.15, for a total value of $239,481.45. Following the transaction, the chief financial officer now owns 276,892 shares in the company, valued […]

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Insider Sells $121,183 87 in Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […]

Coastwise Capital Group LLC Raises Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Coastwise Capital Group LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 11.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,694 shares of the exchange traded fund’s stock after purchasing an additional 465 shares during […]

Masters Capital Management LLC Trims Stock Position in Aspen Aerogels, Inc (NYSE:ASPN)

Masters Capital Management LLC trimmed its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) by 59.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200,000 shares of the construction company’s stock after selling 298,500 shares during […]

Sollinda Capital Management LLC Invests $239,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sollinda Capital Management LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,677 shares of the exchange traded fund’s stock, valued at approximately $239,000. A number of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.